Valuation (21%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 34.02 | 19.60 |
| PEG Ratio (TTM) | 0.34 | -3.02 |
| P/S Ratio (TTM) | N/A | 2.01 |
| P/B Ratio (TTM) | N/A | 4.12 |
| P/FCF Ratio (TTM) | N/A | 10.51 |
| Price to 5YR AVG Earnings Ratio | N/A | 22.59 |
| Price to 5YR AVG FCF Ratio | N/A | -32.20 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | N/A | 3.02% |
| ROE (TTM) | N/A | 11.43% |
| Net Profit Margin (TTM) | N/A | 0.63% |
| ROIC 5YR AVG | N/A | 9.06% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A |
| Net Income | N/A | N/A | N/A |
| Cash Flow | N/A | N/A | N/A |
Health (11%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | 0.84 |
| Quick Ratio (TTM) | N/A | 0.79 |
| D/E Ratio (TTM) | N/A | 1.67 |
| Interest Coverage (TTM) | -1.18 | 6.78 |
| Piotroski F-Score | N/A | 6 |
| Altman Z-Score | 2.43 | 1.08 |
| LTL to 5YR AVG FCF | N/A | -9.12 |
| Shares Outstanding Growth 5YR AVG | N/A | 0.36% |